Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
L.B. Foster | FSTR | Apr 30, 2024 | 23.25 | -3.97 |
L.S. Starrett | SCX | Apr 30, 2024 | 16.11 | -0.25 |
L3Harris Technologies | LHX | Apr 30, 2024 | 214.05 | -1.39 |
La Rosa Company | LRHC | Apr 30, 2024 | 1.65 | -5.17 |
La-Z-Boy | LZB | Apr 30, 2024 | 32.84 | -1.71 |
Labcorp | LH | Apr 30, 2024 | 201.37 | -1.37 |
Ladder Capital | LADR | Apr 30, 2024 | 10.73 | -1.65 |
Laird Superfood | LSF | Apr 30, 2024 | 1.94 | -3.48 |
Lake Shore Bancorp | LSBK | Apr 30, 2024 | 11.61 | -1.11 |
Lakeland Bancorp | LBAI | Apr 30, 2024 | 12.19 | -1.61 |
Lakeland Financial | LKFN | Apr 30, 2024 | 58.77 | -0.66 |
Lakeland Industries | LAKE | Apr 30, 2024 | 16.55 | -2.88 |
Lam Research | LRCX | Apr 30, 2024 | 894.41 | -3.70 |
Lamar Advertising A | LAMR | Apr 30, 2024 | 115.85 | +0.40 |
Lamb Weston | LW | Apr 30, 2024 | 83.34 | -1.57 |
LAMF Global Ventures I SPAC A | LGVC | Apr 30, 2024 | 6.75 | -8.10 |
Lancaster Colony | LANC | Apr 30, 2024 | 190.81 | +0.24 |
Landmark Bancorp | LARK | Apr 30, 2024 | 18.00 | -2.44 |
Landos Biopharma | LABP | Apr 30, 2024 | 22.30 | -0.80 |
Lands End | LE | Apr 30, 2024 | 13.68 | -1.79 |
Landsea Homes | LSEA | Apr 30, 2024 | 11.55 | +0.52 |
Landstar System | LSTR | Apr 30, 2024 | 174.41 | -1.59 |
Lantern Pharma | LTRN | Apr 30, 2024 | 5.10 | +3.45 |
Lantheus | LNTH | Apr 30, 2024 | 66.54 | -1.07 |
Lantronix | LTRX | Apr 30, 2024 | 3.76 | +8.67 |
Lanvin Group | LANV | Apr 30, 2024 | 1.80 | +19.21 |
Lanzatech Global | LNZA | Apr 30, 2024 | 2.17 | -2.48 |
Largecap Core Alphadex First Trust | FEX | Apr 30, 2024 | 94.49 | -1.64 |
Largecap Dividend Wisdomtree | DLN | Apr 30, 2024 | 69.19 | -1.34 |
Largecap ETF Vanguard | VV | Apr 30, 2024 | 230.19 | -1.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.